The overall evidence is in favour of the use of NAC in COPD, and NAC is licensed in many countries as a mucolytic for patients with COPD and other airway diseases, such as cystic fibrosis
Together, these actions accelerate wound healing, improve tissue strength and elasticity, and support homeostatic recovery following injury or inflammation 1,5
It takes time to get the neuroinflammation under control
Giora Pillar, orcid.org/0000-0002-0553-4226 Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Ships to your door Compounded in a US pharmacy and shipped ready to use, no reconstitution required
Aug 2022